- ManufacturerAuditedNon-Compliance ReportIndiaIndiaPakistanWHO GMPEU WCKDMFCEP COS
Supriya Lifescience
ManufacturerAuditedAudit report availableHeadquarters
IndiaSites
IndiaRegulatory compliance
FDAEDQMWHO GMPGDUFAKDMFEU WCNDC APICEP COSAudit standards
GMP (APIs)CSPC Pharmaceutical Group
ManufacturerHeadquarters
People's Republic of ChinaSites
People's Republic of ChinaRegulatory compliance
FDAEDQMGDUFAKDMFJDMFUSDMFCEP COSNDC APIBakul Group
ManufacturerHeadquarters
IndiaSites
IndiaRegulatory compliance
KDMFEU WCNDC APICEP COSCompany description
The Bakul Group of enterprises, situated in Mumbai, India, are involved in the production and fabrication of premium Active Pharmaceutical Ingredients (APIs), Intermediates, and Speciality Chemicals. Since establishment in 1975, they have expanded to achieve global eminence in the field of xanthine chemistry. Their expertise lies in the production of APIs like Linagliptin, Pentoxifylline, Theobromine, Doxofylline, Caffeine, Pamabrom, and others.
Jilin Province Shulan Synthetic Pharmaceutical
ManufacturerHeadquarters
People's Republic of ChinaSites
People's Republic of ChinaRegulatory compliance
KDMFCompany description
Shulan City in Jilin Province is where the Shulan Synthetic Pharmaceutical Co., Ltd. is situated, spreading across 120,000 square meters with a registered capital of 15.758 million yuan. It functions as a national designated producer of caffeine, one of only four in the country. The company is in the process of establishing the largest caffeine production facility globally with an annual capacity of 10,000 tons, to be located in the Jilin Economic Development Zone. Upon completion, the entire company will be relocated to the Jilin Economic Development Zone.
CSPC New Nova Pharmaceutical
ManufacturerHeadquarters
People's Republic of ChinaSites
People's Republic of ChinaRegulatory compliance
EDQMKDMFCEP COSUSDMF